Successful Results: Preliminary findings of a 2 year study individuals undertaken to assess the results of Växa’s Oral Chelation Health-Pac Program.
Individual Physician’s (M.D.) Case Results, n=5

The Benefits of Växa’s Oral Chelation:

Appropriate buffered Chelation such as is provided by the Health-Pac, not only removes heavy metals from the body and helps in the dissolution of calcified plaque within the cardiovascular system, but has shown to improve the general circulation as well. It’s estimated that an increase in just 1mm in diameter of the lumen within veins and arteries will permit a 4-fold increase in blood flow! Such an increase allows fresh oxygenated blood and nutrients to efficiently feed all the cells of the body, as well as aid in the speedy removal of all waste products coming from those cells. A systemic cleansing of the cardiovascular system of this kind can help further support the body’s healing process in a number of ways. Accordingly, an ongoing clinical study of the benefits of Växa’s 3 Step Non-Invasive Oral Chelation Program is yielding some very impressive individual preliminary results of those on the program for just 2-3 months:

Clinical Case Study #1: 100% Increase in Heart Efficiency!
A 75 year old male with a 20 year history of atrial fibrillation (abnormal fluctuations of the heart beat), hypertension (high blood presure), adrenal insufficiency (low adrenalin) and a pacemaker, suffered a cerebrovascular accident (stroke) in October 1996, after he was ironically put on a common blood thinner medication used to prevent strokes. Because of the stroke, he sustained a right hemiparesis (paralysis on the right side) and was subsequently unable to walk or use his right arm. While in the hospital, he was started on loading doses of a number of strategic Växa nutraceutical formulas including AM/PM Regen™, Digestin™, Neuran™, Circulin™, and Anti-Oxin™ suggested in cases of stroke incident.

His response was considered most remarkable. He literally walked out of the hospital just 10 days after sustaining paralysis instead of the 6 to 10 weeks his neurologist had expected, having regained full function of his body and mind. Maintenance doses then continued and he was placed on Buffer-pH+™, TriCardia+™ and Systemex™ secondary to his ECHO cardiogram showing atrial fibrillation, a 25% Ejection Fraction (the measured efficiency of the heart pumping blood to the body) and mild valvular regurgitation (the heart valves were not closing properly). In just 6 weeks after starting TriCardia+™, his 20 year history of atrial fibrillation was completely converted to normal sinus rhythm. One year later, a repeat ECHO cardiogram showed very significant improvement in his cardiac function. The moderate to severly reduced systolic function (E.F. 25%) improved to mildly reduced left ventricular dysfunction with his Ejection Fraction up to 55% (a greater than 100% improvement within one year). The mild valvular insufficiencies were now reduced to trace and minimal regurgitation.

The patient is now back on the golf course and feeling much better, He reports more stamina, no shortness of breath, a steady heartbeat without pacemaker intervention and warm and pink toes which were once cold and white. Please Note: The pateint was also put on Växa’s Immun-Aid+™ and Virexin™ secondary to multiple viral and bacterial infections of the eyes, sinuses, ears and lungs from being on Prednisone® for years for his adrenal insufficiency. He has much less incidence and severity of these infections now. He has been able to reduce his Prednisone® dosage, and is tapering off his blood pressure medication secondary to his falling blood pressure.

Clinical Case Study #2: Cholesterol & Triglycerides Cut in Half!
A 59 year old male with severe hyperlipidemia started the Växa Oral Chelation Program consisting of Buffer-pH+™, TriCardia+™, and Systemex™, with total cholesterol at 444 and triglycerides at 1,659. Two weeks later he was retested and showed a significant decline in blood lipids, with cholesterol down to 287 and triglycerides down to 755. He reports feeling more active and alert, experiences better clarity of memory, vague chest sensations are gone, he is less winded on exertion, has better circulation in fingers and toes, and feels a general sensation of “well being.” His bowel functions are very regular now and he reports an improved complexion, healthier skin and nails, and fewer bruises.

Clinical Case Study #3: Improvement in Kidney Function!
A 46 year old male with a 44 year history of nephritis and an 18 year history of hypertension maintained on multiple pharmaceutical medications, started the Växa Oral Chelation Program consisting of Buffer-pH+™, TriCardia+™ and Systemex™, with blood pressure at 160/90. Just 2 months later, his blood pressure is down 20 points, both systolic and diastolic at 140/70. Testing of his kidneys by his nephrologist showed definite improvement and he was able to start decreasing his Prednisone® doses.

Clinical Case Study #4: Warm and Pink Fingers & Toes!
A 76 year old male with a long-standing history of arteriosclerosis, had symptoms of constantly white and cold fingers and toes. He started the Växa Oral Chelation Program consisting of Buffer-pH+™, TriCardia+™ and Systemex™, and 3 weeks later reported warm and pink fingers and toes for the first time in years. Improved circulation to the extremeties has remained (hands and feet are now continually warm and pink) and he is now on a maintenance program with TriCardia+. He also reports improved bowel regularity and more energy throughout the day.

Clinical Case Study #5: Angina Symptoms Disappeared!
A 52 year old female with ongoing occassional left chest pains and pressure radiating to the left arm with numbness (angina symptoms) for over the past year started the Växa Oral Chelation Program consisting of Buffer-pH+™, TriCardia+™ and Systemex™. After just one month, she no longer exhibited or complained about chest pains, nor radiating pressure or numbness to the leftside and arm. All symptoms of angina disappeared. After 4 months of continuing supervision, no angina symptoms have reoccured. The patient also reports increased energy, no shortness of breath on exertion, improved regularity of bowels, definite improvement of hair, being thicker and healthier looking, and nails are stronger and growing faster.

Please note: Results will vary for each individual. Do not use without a physician’s guidance if you are pregnant, nursing, taking prescriptive medication or if cardiovascular disease is suspected. These are only preliminary findings of 5 individuals who have to date completed the program; some 75 other cases are now in varying stages of completion of the program wherein all but one individual noted specific improvement. For ethical reasons, the design of this study is statistically controlled by using each person as their own control in a sample format of n=1, which will then be followed by the appropriate statistical procedures to analyze the weighted summation of the results of the entire sample size.

General Improvement
In Overall Circulation

Increased Pumping Efficiency of the Heart

Decreased Levels of Cholesterol and Triglycerides

Decreased Blood Pressre